Member Info for CTSFO

54retiresoon.

I have to repost your comment.

“ I would disagree on point 6.

It is better for mankind for Avacta to retain Precision and licence it out to numerous BP to improve their existing drugs or resurrect those which were discontinued as too toxic than for one BP to take control of Precision and control the chemo market.

Value could rapidly rise on license deals and on fast track approval for AVA6000 in STS during the short study by FDA.”

Just think how many drugs showed oncological promise, but their side effects stopped development. The R&D teams of every Onco Pharma company must be thinking will the precision platform work with our drugs?

First Gazette notice re dissolving Tintra PLC on the Companies House website. Don’t know what significance this has.

Not sure if this has ever been mentioned, apologies if it has.

AVA6000 can be administered via a simple back of the hand cannula. Normal doxorubicin HAS to be administered via a central line.

Huge benefits to patient and healthcare providers re ease of IV access, patient pain and safety, not having to live with the constant visual reminder of the disease being treated.

I know cos I asked.

https://www.cancerresearchuk.org/about-cancer/treatment/chemotherapy/how-you-have/into-your-vein/central-lines

I’ve been played, lied to, and trusted ….s

Revenge is a dish best served cold - but very sweet.

Not trying to teach you to suck eggs. It’s worth checking with your broker what your options are. They might automatically sell your ISA shares if the offer is accepted. Especially if the shares are held by the broker on your behalf vs you having a share certificate for them. I don’t know the details of what happens.

One for a broker! It’s a reverse bed n ISA. I’m guessing you have to sell the shares in the ISA and then re-buy them into a trading account. Possible to do this before Tintra is taken private, providing they relist.

I’m new to this share / company. Agree with the sentiment being shared. It’s certainly tracking under the radar at present. Not sure how to boost exposure. I don’t think it has a LinkedIn profile? This might be worth mentioning to the execs? Hopefully good news tomorrow will give the sp a big boost and get it top of the climbers board.

Either an incredible sequence of coincidences or blatant market manipulation. One for the SFO to look at. I